Why the study?
Distinguishing physiological adaptation with mildly reduced resting LVEF from subclinical dilated cardiomyopathy in endurance athletes remains challenging, prompting the hypothesis that LVEF depends on resting HR in athletes but not the general population.
Answers are grounded in this paper and cite their sources.
May link lower heart rate to higher LVEF in athletes; hypothesis-generating and should not change practice.
Endurance athletes commonly exhibit enlarged cardiac chambers,1 and distinguishing between the athlete’s heart and subclinical dilated cardiomyopathy is challenging. Studies have reported that over 10% of highly trained endurance athletes have a resting left ventricular (LV) ejection fraction (EF) below normal limits,2 which underscores the challenge of discerning between physiological adaptation and pathological remodelling. However, these adaptions do not reflect disease in most athletes as a mildly reduced LV EF in elite athletes can be physiologically explained by a large, adaptively developed LV,3 necessitating a lower proportion of the end-diastolic volume to be ejected to maintain the cardiac output that meet the body’s resting metabolic needs. Thus, for endurance athletes with a non-bradycardic resting heart rate (HR), a reduction in stroke volume due to an increased end-systolic volume and reduced LV EF could represent a physiological adaptation aimed at preventing the production of an unnecessary large cardiac output. Consequently, we hypothesize that the LV EF is dependent on resting HR in elite endurance athletes but not in the general population. We used a sample of 15 asymptomatic elite endurance athletes competing at the national and international level in cross-country skiing (n = 7), speed skating (n = 3), triathlon (n = 1), running (n = 2), and cycling (n = 2) and 15 healthy age-matched controls (‘controls’ from here on) recruited from the Royal Norwegian Air Force. Additionally, we included 1170 presumably healthy participants who underwent comprehensive echocardiography and cardiopulmonary exercise testing as a part of their participation in the fitness and echocardiography sub-study of the fourth wave of the Trondelag Health Study (HUNT4). Further information on data collection and methods has been described previously.3,4 Participants with a medical history of angina pectoris, myocardial infarction, heart failure, atrial fibrillation, stroke, chronic obstructive pulmonary disease, use of anti-hypertensives, and diabetes were excluded based on a review of medical records and self-report for the HUNT participants. We also excluded participants with a resting HR ≥ 120 b.p.m. Echocardiography was performed using GE Vivid E95 scanners. Left ventricular volumes and EF were measured using the LVQ package in three-dimensional (3D) recordings and the Simpson biplane method of disc summation in two-dimensional (2D) recordings. The 2D and 3D measurements were acquired within 5–10 min during the same echocardiogram. Heart rates during acquisition of 3D LV EF were available from all three samples and were chosen for the main analyses. We also performed analyses on change in LV EF and HR between 2D and 3D acquisitions for the athletes. Statistical analyses were based on linear regression, odds ratios with 95% Wald confidence intervals (CIs), and the Fisher’s exact test. Mean age was 25 (SD: 6) years in athletes (92% males), 22 (SD: 1) in controls (53% males), and 57 (SD: 12) in HUNT participants (45% males). Athletes had a mean peak oxygen uptake of 71 mL/kg/min (SD: 4), with 2D LV end-diastolic volumes exceeding established reference values in all,5,6 but myocardial thicknesses remained within normal limits (mean: 8.6 mm, SD: 1.0 mm). The mean peak oxygen uptake was 55 mL/kg/min (SD: 5) for the controls and 38 mL/kg/min (SD: 9) in the HUNT sample. The mean 2D LV EF was 54% (SD: 4) in athletes and below 50% in three (23%) compared with only 4.4% of the HUNT participants (mean LV EF: 60%, SD: 5%) and none of the controls (mean LV EF: 57%, SD: 4%). Using the American Society of Echocardiography and the European Association of Cardiovascular Imaging cut-offs of 52% for males and 54% for females,6 five (38%) athletes had LV EF below the lower limit of normality. The odds ratio for an LV EF < 50% was 5.7 (95% CI 1.5–20.7, P = 0.026) for athletes compared with the HUNT participants. Heart rate explained only 0.6% of variance in 3D LV EF for HUNT participants (beta −0.03, adjusted R2 = 0.006, P = 0.006), while HR did not explain any variance for controls (beta −0.02, adjusted R2= −0.07 P = 0.86). In athletes, there was an inverse association between HR and 3D LV EF, in which 21% of the variance was explained (beta −0.28, adjusted R2 = 0.21, P = 0.051), with similar results for 2D LV EF (R2 = 0.28, P = 0.026). Individual data and fitted regression lines are shown in Figure 1. Analyses using different measures of HR are shown in Table 1. In athletes, the change in HR between 2D and 3D acquisitions was numerically, though not statistically significant, associated with the change in LV EF (beta −0.34, R2 = 0.18, P = 0.062). No association was found between 3D LV EF and HR in HUNT participants under the age of 30 (n = 24) and 40 (n = 96) years, respectively. The association of heart rate at echocardiography with left ventricular ejection fraction in athletes for both 3D and 2D echocardiography (A and B), age-matched controls (C), and healthy normal subjects from the Trondelag Health Study (D). Results from linear regression analyses from different measures of left ventricular ejection fraction and heart rate available from the echocardiographic examinations LV, left ventricle; EF, ejection fraction; HR, heart rate; AV, aortic valve; LVOT, left ventricular outflow tract. aHeart rate for athletes based on average from two- and four-chamber views for the EF measurement. Heart rate for HUNT sample and controls based on average from AV and LVOT Doppler and from the 3D LV EF measurement. bHeart rate value based on average from AV and LVOT Doppler and from the 3D LV EF measurement. Results from linear regression analyses from different measures of left ventricular ejection fraction and heart rate available from the echocardiographic examinations LV, left ventricle; EF, ejection fraction; HR, heart rate; AV, aortic valve; LVOT, left ventricular outflow tract. aHeart rate for athletes based on average from two- and four-chamber views for the EF measurement. Heart rate for HUNT sample and controls based on average from AV and LVOT Doppler and from the 3D LV EF measurement. bHeart rate value based on average from AV and LVOT Doppler and from the 3D LV EF measurement. The main finding of this study was the strong correlation between LV EF and HR during echocardiographic examination in elite endurance athletes, a relationship not observed in non-athletes. This implies a physiological explanation, wherein athletes effectively balance large LV end-diastolic volumes, autonomic tone, and cardiac output to prevent energy wastage by aligning cardiac outputs with the physiological demand. Although a low LV EF can be a sign of underlying pathology in some athletes, these data support that the reduced LV EF found in a considerable proportion of endurance athletes is the result of physiological adaptions and not evolving pathology. Consistent with a physiological interpretation of reduced LV EF in elite endurance athletes, a recent study showed that endurance athletes with reduced LV EF exhibited higher contractile reserve by exercise cardiac magnetic resonance imaging and comparable peak oxygen uptake to the athletes with a preserved LV EF.7 These findings also align with the responses observed in another study.8 Given the limited sample size of elite endurance athletes in this report, the results primarily serve as a basis for generating hypotheses and should be validated in more extensive data sets. The HUNT (Nord-Trøndelag Health Study) is a collaboration between the HUNT Research Centre (Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology), Nord-Trøndelag County Council, Central Norway Regional Health Authority, and the Norwegian Institute of Public Health. J.M.L. contributed to the conception and design of the work, data acquisition and analysis, and interpretation of data and drafted the manuscript. B.N., Ø.S., A.E.T., T.F., C.M., M.H., U.W., and H.D. contributed to the acquisition and interpretation of data. All authors revised the manuscript and gave final approval and agree to be accountable for all aspects of work ensuring integrity and accuracy. The work was funded by the Liaison Committee for Education, Research and Innovation in Central Norway, the Norwegian Research Council, the Nord-Trøndelag Hospital Trust, the Norwegian University of Science and Technology, the National Association for Heart and Lung Diseases (LHL), the Simon Fougner Hartmann’s Family Fund, and the Norwegian Defence University College. The data from HUNT are available on application to the HUNT Data Access Committee (https://www.ntnu.edu/hunt/data).
No takes yet. Share an insight, caveat, or question.
Letnes et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: